Screener
Moderna MRNA Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Moderna’s reported figures.
Based on the most recent quarter.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's debt-to-equity?
- Moderna (MRNA) reported debt-to-equity of 0.2× in Q2 2026.
- How has Moderna's debt-to-equity changed year-over-year?
- Moderna's debt-to-equity increased by 123.6% year-over-year, from 0.1× to 0.2×.
- What is the long-term trend for Moderna's debt-to-equity?
- Over 5 years (2020 to 2025), Moderna's debt-to-equity has grown at a 8.5% compound annual growth rate (CAGR), from 0.1× to 0.2×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Moderna's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude